Back to results
US 2016/0355568 A1Published application
Recombinant factor viii proteins
AssigneeBiogen Idec MA Inc.
InventorJohn KULMAN
Life of this patent
Estimating the term…
Abstract
Provided are recombinant Factor VIII proteins, e.g., human Factor VIII proteins with heterologous moieties inserted into flexible permissive loops located in the Factor VIII A domains, while retaining the procoagulant activity of Factor VIII.
Claims32
A recombinant FVIII protein comprising:
- a first polypeptide comprising Formula I:
- (A1)-a1-(A2)-a2-[B];
- and a second polypeptide comprising Formula II:
- a3-(A3)-(C1);
- wherein the first polypeptide and the second polypeptide are fused or exist as a heterodimer;
- wherein, a) A1 is an A1 domain of FVIII;
- b) A2 is an A2 domain of FVIII;
- c) [B] is a B domain of FVIII, a fragment thereof, or is deleted;
- d) A3 is an A3 domain of FVIII;
- e) C1 is a C1 domain of FVIII;
- f) a1, a2, and a3 are acidic spacer regions;
- wherein the A1 domain comprises a permissive loop-1 (A1-1) region and a permissive loop-2 (A1-2) region;
- wherein the A2 domain comprises a permissive loop-1 (A2-1) region and a permissive loop-2 (A2-2) region;
- wherein the A3 domain comprises a permissive loop-1 (A3-1) region and a permissive loop-2 (A3-2) region;
- wherein at least one of the regions A1-1, A1-2, A2-1, A2-2, A3-1, A3-2, or a3 comprises a heterologous moiety;
- and
- wherein the recombinant FVIII protein exhibits procoagulant activity.
14 more elements
2-5. (canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
17-18. (canceled)
23-25. (canceled)
27-29. (canceled)
31-39. (canceled)
43-44. (canceled)
48-110. (canceled)
Dependencies are inferred from the claim text.